UniProtKB/Swiss-Prot Q9H427: Variant p.Thr260Pro

Potassium channel subfamily K member 15
Gene: KCNK15
Feedback?

Variant information Variant position:

260 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Threonine (T) to Proline (P) at position 260 (T260P, p.Thr260Pro). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and polar (T) to medium size and hydrophobic (P) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Polymorphism:

Three alleles are known: TASK-5A, TASK-5B and TASK-5C. The sequence shown is that of allele TASK-5B. Additional information on the polymorphism described.
Variant description:

In allele TASK-5A and allele TASK-5C. Any additional useful information about the variant.
Other resources:

Links to websites of interest for the variant.

Variant rs6073538 [ dbSNP | Ensembl ]

Sequence information Variant position:

260 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

330 The length of the canonical sequence.
Location on the sequence:

NLVVLRFLVASADWPERAAR T PSPRPPGAPESRGLWLPRRP The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         NLVVLRFLVASADWPERAA-RTPSPRPPGAPESRGLWLPRRP

Rat                           NLVVLRFL-ASAEAPERAALRRASVFRRGAPESR-------

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 330	Potassium channel subfamily K member 15
Topological domain	244 – 330	Cytoplasmic
Region	256 – 276	Disordered

Literature citations
KT3.2 and KT3.3, two novel human two-pore K(+) channels closely related to TASK-1.
Vega-Saenz de Miera E.; Lau D.H.P.; Zhadina M.; Pountney D.; Coetzee W.A.; Rudy B.;
J. Neurophysiol. 86:130-142(2001)
Cited for: NUCLEOTIDE SEQUENCE [MRNA]; VARIANTS GLY-95; PRO-260 AND PRO-323; Expression pattern in brain of TASK-1, TASK-3, and a tandem pore domain K(+) channel subunit, TASK-5, associated with the central auditory nervous system.
Karschin C.; Wischmeyer E.; Preisig-Mueller R.; Rajan S.; Derst C.; Grzeschik K.-H.; Daut J.; Karschin A.;
Mol. Cell. Neurosci. 18:632-648(2001)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA]; POLYMORPHISM; VARIANTS GLY-95; PRO-260; HIS-261 AND PRO-323; MUTAGENESIS OF ARG-138; 141-LEU--CYS-145; TRP-151 AND CYS-153; TASK-5, a novel member of the tandem pore K+ channel family.
Ashmole I.; Goodwin P.A.; Stanfield P.R.;
Pflugers Arch. 442:828-833(2001)
Cited for: NUCLEOTIDE SEQUENCE [MRNA]; VARIANTS GLY-95; PRO-260 AND PRO-323; TISSUE SPECIFICITY;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.